GERN

NASDAQ · Equity

Geron Corporation

US Healthcare Biotechnology

Latest week
29 May 2026
Close
1.250000
Fair value
2.458141
Expectation
Undecided 45.34%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
1.25
12-Week Change
-20.89%
Trend Signal
Inactive
Expectation
Undecided 45.34%
Signal Weeks
10 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-27.00
Market Dynamics
-0.92

Over the latest 12 completed weeks ending 2026-05-29, GERN fell 20.89%, moving from 1.58 to 1.25. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 10 of the last 12 weeks. Relative Strength is -27.00 and has softened across the 12-week window. Market Dynamics is -0.92 on the latest week. Expectation is undecided at 45.34%.